PSM15: Non-comparative Study to Assess the Visual Performances and Safety of a Progressive Multifocal Intraocular Lens

Sponsor
SIFI SpA (Industry)
Overall Status
Completed
CT.gov ID
NCT02838004
Collaborator
Opera CRO, a TIGERMED Group Company (Other)
77
1
1
14
5.5

Study Details

Study Description

Brief Summary

This is an interventional, non-controlled, multicenter international trial with a prospective design on one cohort of patients.

Condition or Disease Intervention/Treatment Phase
  • Device: IOL MINI WELL READY
N/A

Detailed Description

To evaluate if the positive results (to assure a good visual acuity at all distances and a good quality of life in terms of glasses independence and absence of undesired events), obtained experimentally using the IOL MINI WELL READY, can be confirmed in the practical surgical routine with a population belonging to different EU countries

Study Design

Study Type:
Interventional
Actual Enrollment :
77 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
An Open Label, Non-comparative Study to Assess the Visual Performances and Safety of a Progressive Multifocal Intraocular Lens With Extended Depth of Focus
Actual Study Start Date :
Aug 1, 2016
Actual Primary Completion Date :
Oct 1, 2017
Actual Study Completion Date :
Oct 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Single arm receiving Mini WELL Ready IOL

IOL implantation for cataract

Device: IOL MINI WELL READY
IOL MINI WELL READY

Outcome Measures

Primary Outcome Measures

  1. UDVA (Uncorrected Distance Visual Acuity) [30 days]

    Visual acuity mesurement

Secondary Outcome Measures

  1. Adverse Device Effects (ADE); Serious Adverse Device Effects (SADE); Unexpected Serious Adverse Device Effects (USADE); Adverse Events (AE); Serious Adverse Events (SAE). [4 months]

    Safety assessment

Other Outcome Measures

  1. Visual Acuity Evaluation [4 months]

    Corrected Distance Visual Acuity (CDVA)

  2. Visual Acuity Evaluation [4 months]

    Uncorrected Near Visual Acuity (UNVA)

  3. Visual Acuity Evaluation [4 months]

    Distance-Corrected Near Visual Acuity (DCNVA)

  4. Visual Acuity Evaluation [4 months]

    Corrected Near Visual Acuity (CNVA)

  5. Visual Acuity Evaluation [4 months]

    Uncorrected Intermediate Visual Acuity (UIVA)

  6. Visual Acuity Evaluation [4 months]

    Distance-Corrected Intermediate Visual Acuity (DCIVA)

  7. Halos and Glare evaluation [4 months]

    Onset of halos Onset of glare during night vision

  8. Contrast sensitivity [4 months]

    Contrast sensitivity, at 3 meters, under photopic conditions and with the correction for distance, using YANG SMART (SIFI Medtech), with sine wave gradings (''vistech")

  9. Reading Performance [4 months]

    Reading Performance tested with Radner Reading Chart - Precision Vision: The test will be performed from the largest to the smallest size of letters in two sessions: Binocular, without the correction for distance, at 40 cm Binocular, with the correction for distance, at 40 cm

  10. Defocus Curve [4 months]

    Binocular defocus curves with step of 0.5 D (from +2.0 to -5.0 D) under photopic conditions.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Any gender and age above 18 years.

  • Refractive lens exchange (RLE) or cataract surgery.

  • Healthy corneas, not treated surgically.

  • Patients willing to have surgery in both eyes in a short period of time (within 2 weeks).

  • Patients request to receive the IOL MINI WELL READY implant

Exclusion Criteria:
  • Previous corneal surgery (i.e. pterygium, refractive surgery).

  • Eye diseases determining a probable postoperative visual acuity < 20/40.

  • Pseudoexfoliation.

  • Abnormal pupil size and position.

  • Use of contact lens 30 days before the preoperative visit.

  • Corneal warpage.

  • Predicted postoperative corneal astigmatism higher than 1 D.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Prof.Dr. Gerd U. Auffarth Heidelberg Germany

Sponsors and Collaborators

  • SIFI SpA
  • Opera CRO, a TIGERMED Group Company

Investigators

  • Principal Investigator: GERD U. AUFFARTH, Prof. Dr., RUPRECHT KARLS UNIVERSITATS AUGENKLINIK HEIDELBERG

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
SIFI SpA
ClinicalTrials.gov Identifier:
NCT02838004
Other Study ID Numbers:
  • PSM15
First Posted:
Jul 20, 2016
Last Update Posted:
Jan 14, 2020
Last Verified:
Jan 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by SIFI SpA
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 14, 2020